Litcius/Paper detail

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

Evan Gross, Mingjia Li, Ming Yin, Delaney Orcutt, Duncan Hussey, Elliot Trott, Sarah K. Holt, Erin R. Dwyer, Joel H. Kramer, Kaylee Oliva, John L. Gore, George R. Schade, Daniel W. Lin, Scott S. Tykodi, Evan Hall, John A. Thompson, Anish B. Parikh, Yuanquan Yang, Katharine A. Collier, Abdul Miah, Sherry Mori-Vogt, Megan Hinkley, Amir Mortazavi, Paul Monk, Edmund Folefac, Steven K. Clinton, Sarah P. Psutka

2022Urologic Oncology Seminars and Original Investigations26 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRenal cell carcinomaInternal medicineSystemic therapyRetrospective cohort studyProportional hazards modelClinical endpointOncologyKidney cancerCohortCancerNephrectomySurgeryUrologyClinical trialKidneyBreast cancerRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers